Role of gene therapy in the future treatment of haemophilia patients

In Special Issue 9 of 2019 W. Miesbach (Institute of Transfusion Medicine, University Hospital Frankfurt) described the role of gene therapy in the future treatment of haemophilia patients.

Related items

Analytical Information : 6

Cases : 5

Guidelines : 1

Haemostatic Cascade : 6

Quality Issues : 3

Analytical Information

Assays

Cases

ECAT Documentation

Guidelines

Haemostatic Cascade

Parameter

Quality Issues

Surveys and Studies

Terminology

Role of gene therapy in the future treatment of haemophilia patients

Related items

Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays

The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies

Results of a workshop on the inter-laboratory variability of analysis of type 1 factor VIII Inhibitors

The do’s and don’ts of laboratory detection of haemostasis-inhibitors: lessons from a workshop

Analytical performance specifications for hemostasis parameters

The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys

Haemophilia B and treatment, case study

Haemophilia A and treatment, case study

A severe haemophilia A patient treated with emicizumab, case study

Acquired haemophilia A

Acquired Hemophilia A, case study

Recommendations for laboratory measurement of factor VIII and FIX type I inhibitors, ICSH recommendations

TF Pathway (Extrinsic) with Common Pathway (PT)

Intrinsic Pathway APTT

Coagulation Pathways (All Components)

Activation of TAFI by Thrombin

Activation of Protein C by Thrombin

Activation of Platelets by Thrombin

Quality Assurance of replacement therapy and future perspectives

External quality assessment for Factor VIII and Factor IX

The between-laboratoy variation of Factor VIII inhibitor testing

Clotpedia

© 2022 ECAT Clotpedia All Rights Reserved

ECAT Foundation
P.O. Box 107
2250 AC Voorschoten | The Netherlands
Email: info@ecat.nl
T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

Clotpedia Support Form

Success

Role of gene therapy in the future treatment of haemophilia patients

Related items

ECAT Foundation P.O. Box 107 2250 AC Voorschoten | The Netherlands Email: info@ecat.nl T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

ECAT Foundation
P.O. Box 107
2250 AC Voorschoten | The Netherlands
Email: info@ecat.nl
T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919